Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
Our team is committed to supporting you every step of the way, ensuring your weight loss journey is safe, effective, and sustainable
This treatment targets three key hormone pathways
Everything for IVY RX is done online through their secure portal, I didnt need to get on the phone with a Dr
Click here
How did we get here, what are payers thinking and doing about it, and how can Rx Savings Solutions help their GLP-1 coverage and cost strategies
